ANOVA F-test results and regulators [🇷 for BE/BA]

posted by d_labes  – Berlin, Germany, 2015-06-12 17:23 (3571 d 11:57 ago) – Posting: # 14950
Views: 14,206

Dear Helmut,

❝ ...

❝ ❝ But regulators like to see some sort of effect tests in the ANOVA ...


❝ ... I never gave anything but the PE and CI in the main text of my reports (the complete eva­lu­ation only in the appendix).


Here we are two, or more than 2 :cool:

❝ Although some assessors or inspectors routinely re­cal­cu­late studies (in SAS or in the semi-secret WinBE?) I never received a ques­tion. Maybe they compared only the CI, which – as you said – is the only relevant part.


May I call you Felix the Fortunate, the Happy? :-D

We received then and when (not so seldom!) questions about the ANOVA F-test results. Up to the request to comment significant results even for the treatment effects, of no relevance in case of BE studies of course.
Nasty the requests to comment the "validity" of the BE evaluation if period and/or sequence effects are found significant. As they many times come out if Type I tests will be applied, especially for sequence.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,670 registered users;
18 visitors (0 registered, 18 guests [including 4 identified bots]).
Forum time: 04:21 CET (Europe/Vienna)

An expert is one who knows more and more
about less and less.    Nicholas Murray Butler

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5